Insmed (INSM) PT Raised to $121 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Insmed (INSM) PT Raised to $110 at Evercore ISI
June 11, 2025 5:14 AM EDTEvercore ISI analyst Liisa Bayko raised the price target on Insmed (NASDAQ: INSM) to $110.00 (from $90.00) while maintaining a Outperform rating.
The analyst comments "INSM delivered outstanding data on BOTH PVR & 6MWD, handedly beating our and investor expectations, which were already... More
